National Center for Advancing Translational Sciences
Government agency, FunderROROpenAlexWikidata
People
Elizabeth Ottinger
Philip Sanderson
Marc Ferrer-Alegre
Sources: reporter.nih.gov
Part of
Sources: wikidata.org
Founded
Founded
Jan 1, 2012
Sources: ror.org
Trials
Collaborator, Not yet recruiting, 40 people
Collaborator, Not yet recruiting, 60 people
A Decision Support Tool for Pancreatic Cancer Screening -Aim 2
Collaborator, Not yet recruiting, 40 people, Sep 9, 2026
Collaborator, Recruiting, 18 people, Sep 8, 2026
BRIDGE Trial: Embedding Consumer-grade mHealth Technologies Into Cardiac Rehabilitation
Collaborator, Recruiting, 30 people, Aug 3, 2026
Superior Parietal iTBS for PD-MCI
Collaborator, Recruiting, 30 people, Jul 14, 2026
Upadacitinib in Treatment of JAK/STAT Pathway Disorders With Activating Mutations
Collaborator, Phase 1/2, Not yet recruiting, 30 people, Jun 26, 2026
Collaborator, Recruiting, 30 people, Jun 1, 2026
In Vivo Imaging of the Olfactory Epithelium Using Confocal Laser Endomicroscopy
Collaborator, Early phase 1, Not yet recruiting, 36 people, Apr 23, 2026
Collaborator, Phase 3, Recruiting, 15 people, Mar 10, 2026
Collaborator, Active, not recruiting, 40 people, Feb 23, 2026
Collaborator, Phase 4, Recruiting, 30 people, Dec 2, 2025
Cessation of Dual Use of Cigarettes and E-cigarettes During Pregnancy
Collaborator, Recruiting, 45 people, Aug 15, 2025
Remote vs. In-Person Study Evaluation (RISE) Trials: RISE Above Smoking (Trial 1 of 3)
Collaborator, Phase 2/3, Completed, 200 people, Feb 12, 2025
Investigating Metabolic and Psychological Adaptations in a Clinical Trial
Collaborator, Completed, 12 people, Jan 30, 2025
Collaborator, Phase 1/2, Not yet recruiting, 24 people, Jan 24, 2025
Ketamine Effects on Learning In Eating Disorders
Collaborator, Phase 2, Enrolling by invitation, 20 people, Dec 17, 2024
In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial
Collaborator, Phase 1/2, Recruiting, 40 people, Nov 26, 2024
Collaborator, Phase 1/2, Withdrawn, 0 people, Nov 25, 2024
Intravenous Ketamine for Treatment-Resistant Depression
Collaborator, Phase 2, Recruiting, 30 people, Oct 31, 2024
Sources: clinicaltrials.gov
Grants and prizes
National Center for Advancing Translational Sciences
ZIA, Use of Rapamycin for the Treatment of Hypertrophic Cardiomyopathy in Patients with Noonan Syndrome with Multiple Lentigines (NSML), ZIATR000012, $995K
National Center for Advancing Translational Sciences
ZIA, Phenotypic Assay Design and Development for Rare and Neglected Diseases, ZIATR000052, $401K
National Center for Advancing Translational Sciences
ZIA, Stem Cell Translation Laboratory (SCTL), ZIATR000244, $5M
National Center for Advancing Translational Sciences
ZIA, Therapy for Fuchs Endothelial Corneal Dystrophy, ZIATR000280, $3.2M
National Center for Advancing Translational Sciences
ZIA, Identification and characterization of novel senolytic agents, ZIATR000335, $40.8K
National Center for Advancing Translational Sciences
ZIA, Identifying selective USP16 inhibitors to sustain stem cell proliferation, ZIATR000324, $128K
National Center for Advancing Translational Sciences
ZIA, 3D Bioprinted retina models for drug screening, ZIATR000399, $995K
National Center for Advancing Translational Sciences
ZIA, Bioactive small molecule development- LATS program, ZIATR000563, $456K
Sources: reporter.nih.gov
Grants and prizes awarded
Elizabeth Ottinger
ZIA, Use of Rapamycin for the Treatment of Hypertrophic Cardiomyopathy in Patients with Noonan Syndrome with Multiple Lentigines (NSML), ZIATR000012
National Center for Advancing Translational Sciences
ZIA, Use of Rapamycin for the Treatment of Hypertrophic Cardiomyopathy in Patients with Noonan Syndrome with Multiple Lentigines (NSML), ZIATR000012, $995K
ZIA, Phenotypic Assay Design and Development for Rare and Neglected Diseases, ZIATR000052
National Center for Advancing Translational Sciences
ZIA, Phenotypic Assay Design and Development for Rare and Neglected Diseases, ZIATR000052, $401K
ZIA, Stem Cell Translation Laboratory (SCTL), ZIATR000244
National Center for Advancing Translational Sciences
ZIA, Stem Cell Translation Laboratory (SCTL), ZIATR000244, $5M
Philip Sanderson
ZIA, Therapy for Fuchs Endothelial Corneal Dystrophy, ZIATR000280
National Center for Advancing Translational Sciences
ZIA, Therapy for Fuchs Endothelial Corneal Dystrophy, ZIATR000280, $3.2M
Marc Ferrer-Alegre
ZIA, Identification and characterization of novel senolytic agents, ZIATR000335
National Center for Advancing Translational Sciences
ZIA, Identification and characterization of novel senolytic agents, ZIATR000335, $40.8K
ZIA, Identifying selective USP16 inhibitors to sustain stem cell proliferation, ZIATR000324
National Center for Advancing Translational Sciences
ZIA, Identifying selective USP16 inhibitors to sustain stem cell proliferation, ZIATR000324, $128K
ZIA, Stem Cell Translation Laboratory (SCTL), ZIATR000244
ZIA, Stem Cell Translation Laboratory (SCTL), ZIATR000244
ZIA, 3D Bioprinted retina models for drug screening, ZIATR000399
National Center for Advancing Translational Sciences
ZIA, 3D Bioprinted retina models for drug screening, ZIATR000399, $995K
ZIA, Bioactive small molecule development- LATS program, ZIATR000563
National Center for Advancing Translational Sciences
ZIA, Bioactive small molecule development- LATS program, ZIATR000563, $456K
R03, Subjective Cognitive Dysfunction in Adults with Systemic Lupus Erythematosus Across the Lifespan, R03TR005820, 2026–2028, Sep 14, 2026
R03, Subjective Cognitive Dysfunction in Adults with Systemic Lupus Erythematosus Across the Lifespan, R03TR005820, $179K, 2026–2028, Sep 14, 2026
Sources: reporter.nih.gov
Funded papers
Mar 1, 2027
Feb 1, 2027
Nov 18, 2026
UL1TR002378, Nov 18, 2026
Sleep–cognition associations change direction with proximity to dementia diagnosis
TL1TR001858, Nov 17, 2026
A circuit mechanism for psychosis vulnerability during perimenopause
T32TR004545, Nov 17, 2026
Beyond Segmentation: Coronary Artery Calcium Scoring with Frozen Self-Supervised CT Features
UL1TR001998, Nov 16, 2026
UL1TR000448, Nov 13, 2026
Liver radiomics on routine cardiac CT identifies hepatic stress states that predict heart failure
UL1TR002243, Nov 10, 2026
Item‐level verbal fluency psycholinguistic metrics predict preclinical Alzheimer's disease
UL1TR001450, Nov 2, 2026
1UL1TR001430, Nov 2, 2026
The EHR-Driven Dysglycemia Risk Score (D-RISK) Predicts Future Development of Type 2 Diabetes
UL1 TR003163
Nov 1, 2026
Nov 1, 2026
Nov 1, 2026
Nov 1, 2026
Metformin at the Time of COVID-19 Infection and Risk of Long COVID: A Target Trial Emulation Study
UM1TR004406, Nov 1, 2026
UL1TR001450
Sources: api.crossref.org, pubmed.ncbi.nlm.nih.gov
Named in competing interests
Cardiovascular Health in Women: Navigating Menopause and Beyond
Grants or research support, Sep 11, 2026
PPV23 Vaccination and Risk of Cardiovascular Events: A Meta-Analysis
Grants or research support, Aug 17, 2026
Grants or research support, Aug 11, 2026
Conditions Attributable to Obesity in Older Adults in the U.S.: A Cross-Sectional Study
Grants or research support, May 17, 2026
Grants or research support, Mar 16, 2026
Grants or research support, Feb 26, 2026
Heart Failure Prevention: Evidence Generation, Trial Design, and Regulatory Pathways
Grants or research support, Feb 11, 2026
Consulting or advice, Fees or honoraria, Grants or research support, Dec 1, 2025
Grants or research support, Nov 20, 2025
Grants or research support, Nov 11, 2025
Examination of metabolic syndrome in Down syndrome and association with dementia
Grants or research support, Oct 1, 2025
Grants or research support, Aug 13, 2025
Grants or research support, Jul 8, 2025
Mechanical thrombectomy in elderly stroke patients with low ASPECTS: insights from STAR
Grants or research support, Jun 1, 2025
Grants or research support, May 15, 2025
Fees or honoraria, Apr 30, 2025
Grants or research support, Mar 29, 2025
Grants or research support, Dec 3, 2024
Heart Failure Risk Among African-American Women With an ICAM1 Missense Variant
Grants or research support, Mar 25, 2024
Nontraditional Risk Markers for Incident Coronary Artery Calcium Among Persons ≥65 Years of Age
Grants or research support, Dec 19, 2023
Sources: pubmed.ncbi.nlm.nih.gov
Papers
Metformin at the Time of COVID-19 Infection and Risk of Long COVID: A Target Trial Emulation Study
Journal of medical virology, Oct 29, 2026
Heart tracing model matched rivals with less training data
The Lancet. Digital health, Sep 1, 2026
KRAKEN: A provenance-tracked knowledge graph for multiomic and wellness research
bioRxiv, Aug 22, 2026
bioRxiv, Aug 7, 2026
Biofabrication and biomedical manufacturing research frontiers in the United States
Bio-Design and Manufacturing, Jul 1, 2026
Physiology, May 1, 2026
medRxiv, Mar 25, 2026
OMICmAge quantifies biological age by integrating multi-omics with electronic medical records
Nature aging, Feb 26, 2026
Pharmacologic activation of Δ133p53α reduces cellular senescence in progeria patients-derived cells
Aging pathobiology and therapeutics, Sep 29, 2025
Pharmacologic activation of Δ133p53α reduces cellular senescence in progeria patients-derived cells
bioRxiv : the preprint server for biology, Aug 6, 2025
ACS pharmacology & translational science, Aug 4, 2025
ADA Scientific Sessions 2025 abstract, Jun 13, 2025
Sex differences in epigenetic ageing for older people living with HIV
EBioMedicine, Feb 10, 2025
Journal of neurologic physical therapy : JNPT, Feb 6, 2025
Molecular cancer therapeutics, Oct 12, 2024
Inflammation and aging-related disease: A transdisciplinary inflammaging framework
GeroScience, Oct 1, 2024
Psychosomatic medicine, Nov 20, 2023
bioRxiv : the preprint server for biology, Oct 31, 2023
Metabolomic epidemiology offers insights into disease aetiology
Nature metabolism, Oct 24, 2023
The Effects of Exercise on Telomere Length in Persons With Heart Failure
The Journal of cardiovascular nursing, Oct 6, 2023